Found: 19
Select item for more details and to access through your institution.
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30594-z
- By:
- Publication type:
- Article
Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 8, p. 1072, doi. 10.1177/1352458516672015
- By:
- Publication type:
- Article
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 10, p. 1371, doi. 10.1177/1352458515615954
- By:
- Publication type:
- Article
Benign neuromyelitis optica is rare in Japanese patients.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 9, p. 1204, doi. 10.1177/1352458514560927
- By:
- Publication type:
- Article
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24 h monitoring.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 607, doi. 10.1111/bcp.12697
- By:
- Publication type:
- Article
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0224419
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome (PRES) of the isolated brainstem.
- Published in:
- Clinical Case Reports, 2022, v. 10, n. 4, p. 1, doi. 10.1002/ccr3.5712
- By:
- Publication type:
- Article
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 4, p. 1996, doi. 10.1007/s00415-021-10764-7
- By:
- Publication type:
- Article
Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 1145, doi. 10.1007/s00415-018-8813-z
- By:
- Publication type:
- Article
Validation of the Japanese version of the Modified Fatigue Impact Scale and assessment of the effect of pain on scale responses in patients with multiple sclerosis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 4, p. 409, doi. 10.1111/cen3.12236
- By:
- Publication type:
- Article
Multiple enhancing brain lesions after discontinuation of fingolimod in a patient with multiple sclerosis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2014, v. 5, p. 52, doi. 10.1111/cen3.12163
- By:
- Publication type:
- Article
Upbeat nystagmus at caudal brainstem lesions in four cases with multiple sclerosis and its related disorders.
- Published in:
- Clinical & Experimental Neuroimmunology, 2013, v. 4, n. 2, p. 206, doi. 10.1111/cen3.12013
- By:
- Publication type:
- Article
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38893-1
- By:
- Publication type:
- Article
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38893-1
- By:
- Publication type:
- Article
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0184012
- By:
- Publication type:
- Article